Preferred Label : Angioedema, hereditary, 1;
Symbol : HAE1;
CISMeF acronym : HAE1; HAE2; HANE;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Angioneurotic edema, hereditary; C1 esterase inhibitor deficiency; HANE; Angioedema, hereditary, type I;
Included titles and symbols : Angioedema, hereditary, type II; HAE2; Angioedema, hereditary, 2;
Description : Hereditary angioedema (HAE) is an autosomal dominant disorder characterized by episodic
local subcutaneous edema and submucosal edema involving the upper respiratory and
gastrointestinal tracts. There are 2 classic types of the disorder. In type I, representing
85% of patients, serum levels of C1NH are less than 35% of normal (Cicardi and Agostoni,
1996; Bowen et al., 2001). In type II, the levels are normal or elevated, but the
protein is nonfunctional. The 2 types are clinically indistinguishable. See 300145
for a discussion of angioedema induced by ACE inhibitors. Zuraw (2008) provided a
detailed review of the clinical features, management, and pathogenesis of hereditary
angioedema.;
Inheritance : Autosomal dominant; Autosomal recessive;
Molecular basis : Caused by mutation in the C1 esterase inhibitor gene (C1NH, 106100.0001);
Laboratory abnormalities : C1 esterase inhibitor deficiency; Low level of C4 and C2;
Prefixed ID : #106100;
Origin ID : 106100;
UMLS CUI : C2717906;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT